Full Committee Hearing

Drug Pricing in America: A Prescription for Change, Part III

Date: Tuesday, April 9, 2019 Time: 10:15 AM Location: 215 Dirksen Senate Office Building

Open in New Window

Member Statements

  1.  Chuck Grassley (R - IA)
  2.  Ron Wyden (D - OR)

Witnesses

  1. Steve Miller, MD
    Executive Vice President and Chief Clinical Officer
    Cigna Corporation
    Bloomfield , CT
  2. Derica Rice
    Executive Vice President and President
    CVS Health and CVS Caremark
    Woonsocket , RI
  3. William Fleming, Pharm.D.
    Segment President, Healthcare Services
    Humana Inc.
    Louisville , KY
  4. John Prince
    Chief Executive Officer
    OptumRx
    Minnetonka , MN
  5. Mike Kolar, JD
    Interim President & CEO, Senior Vice President and General Counsel
    Prime Therapeutics LLC
    Eagan , MN

Related Files

Drug Pricing in America: A Prescription for Change, Part III

 How do I submit a statement for the record?

Any individual or organization wanting to present their views for inclusion in the hearing record should submit in a Word document, a single-spaced statement, not exceeding 10 pages in length. No other file type will be accepted for inclusion. Title and date of the hearing, and the full name and address of the individual or organization must appear on the first page of the statement. Statements must be received no later than two weeks following the conclusion of the hearing.

Statements can be emailed to:

Statementsfortherecord@finance.senate.gov

Statements should be mailed (not faxed) to:

Senate Committee on Finance
Attn. Editorial and Document Section
Rm. SD-219
Dirksen Senate Office Bldg.
Washington, DC 20510-6200